Pneumococcal infections

Pneumococcal infections most often affect vulnerable individuals (people with chronic illnesses, young children, older adults, etc.), but they can be prevented through vaccination.

Our missions

  • Monitoring the epidemiological trends of invasive pneumococcal infections and assessing the impact of vaccination

  • Promote vaccination

  • Informing healthcare professionals and the general public

The Disease

Pneumococcal infections are caused by the bacterium Streptococcus pneumoniae. These invasive infections can be serious and usually require hospitalization.

Pneumococcal infections, a major cause of morbidity and mortality

Pneumococcal infections are caused by a bacterium called Streptococcus pneumoniae. Pneumococci can cause infections in many parts of the body: the middle ear (otitis) in children, the sinuses (sinusitis) in adults, the membranes surrounding the brain (meningitis), the blood (bacteremia), and the lungs (pneumonia).
When pneumococci spread to a normally sterile site, such as the blood (bacteremia or sepsis), the meninges (meningitis), or a joint (arthritis), pneumococcal infections are referred to as invasive. Such infections can be serious and usually require hospitalization.

These infections most commonly affect young children, the elderly, and people with chronic diseases or who are taking medications that weaken their immune defenses against infections. In fact, the risk of developing a pneumococcal infection is four times higher in the presence of a chronic condition, such as diabetes, lung disease, heart disease, or alcoholism, and by 23 to 48 in patients who are immunocompromised due to cancer or HIV/AIDS.

According to the World Health Organization (WHO), more than 800,000 children under the age of 5 die each year worldwide from pneumococcal infections.
The mortality rate for invasive pneumococcal infections ranges from 10% to 30% depending on the study and increases with age and the presence of comorbidities.
In France, pneumococci are the leading cause of community-acquired bacterial pneumonia and bacterial meningitis in adults.

Key Statistics on Pneumococcal Disease

1re cause de pneumonie bactérienne communautaire et de méningite chez l'adulte ; 10 à 30% de mortalité estimée ; plus de 800 000 enfants de moins de 5 ans meurent chaque année dans le monde

Transmission through direct, close contact

Pneumococci are transmitted from person to person through direct, close contact with an infected person or carrier, particularly through kissing, coughing, or sneezing.

Prevention through vaccination

Pneumococci are highly diverse: more than 90 "The set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allows for the differentiation of strains belonging to the same species." data-tooltip-title="The set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allows for the differentiation of strains belonging to the same species." data-tooltip-content="" data-tooltip-placeholder-is-selection="true" data-tooltip-placeholder-is-selection-text="serotypes" data-tooltip-data="%5B%7B%22tooltipTitle%22%3A%22The%20set%20of%20antigenic%20characteristics%20of%20certain%20microorganisms%20(bacteria, viruses, fungi), which allow for the differentiation of strains belonging to%C3%A0%20the%20same%20species.%22%2C%22tooltipContent%22%3A%22%22%2C%22placeholderIsSelection%22%3A%22true%22%2C%22placeholderIsSelectionText%22%3A%22serotypes%22%7D%5D">serotypes have been identified and are defined by their capsular antigen. These "Set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allow strains belonging to the same species to be distinguished." data-tooltip-title="The set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allows for the differentiation of strains belonging to the same species." data-tooltip-content="" data-tooltip-placeholder-is-selection="true" data-tooltip-placeholder-is-selection-text="serotypes" data-tooltip-data="%5B%7B%22tooltipTitle%22%3A%22The%20set%20of%20antigenic%20characteristics%20of%20certain%20microorganisms%20(bacteria, viruses, fungi), which allow for the differentiation of strains belonging to%C3%A0%20the%20same%20species.%22%2C%22tooltipContent%22%3A%22%22%2C%22placeholderIsSelection%22%3A%22true%22%2C%22placeholderIsSelectionText%22%3A%22serotypes%22%7D%5D">serotypes differ in terms of their virulence and antibiotic resistance profiles. Pneumococcal vaccines target pneumococci from the approximately twenty "Set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allow strains belonging to the same species to be distinguished." data-tooltip-title="The set of antigenic characteristics of certain microorganisms (bacteria, viruses, fungi) that allows for the differentiation of strains belonging to the same species." data-tooltip-content="" data-tooltip-placeholder-is-selection="true" data-tooltip-placeholder-is-selection-text="serotypes" data-tooltip-data="%5B%7B%22tooltipTitle%22%3A%22The%20set%20of%20antigenic%20characteristics%20of%20certain%20microorganisms%20(bacteria, viruses, fungi), which allow for the differentiation of20strains%20belonging%20to%20the%20same%20species.%22%2C%22tooltipContent%22%3A%22%22%2C%22placeholderIsSelection%22%3A%22true%22%2C%22placeholderIsSelectionText%22%3A%22serotypes%22%7D%5D">serotypes primarily involved in invasive infections.

Vaccination Recommendations

General Recommendations

Pneumococcal vaccination is mandatory starting at 2 months of age for all infants born on or after January 1, 2018. This vaccination is required for children to enter or remain in group settings.

Specific Recommendations

Pneumococcal vaccination is recommended for children over 2 years of age, adolescents, and adults who are immunocompromised or have a chronic condition that predisposes them to invasive pneumococcal infection, as well as for all individuals aged 65 and older. The immunogenicity of the vaccines may be lower in this population, which explains the recommendation for specific vaccination schedules.
Vaccination is recommended for people in the following situations:

  • Immunocompromised patients:
    • asplenic or hyposplenic individuals (including those with major forms of sickle cell disease)
    • with inherited immune deficiencies
    • HIV-infected individuals, regardless of immunological status
    • undergoing chemotherapy for solid tumors or hematologic malignancies
    • who have undergone or are awaiting solid organ transplantation
    • patients who have undergone hematopoietic stem cell transplantation
    • being treated with immunosuppressants, biologics, and/or corticosteroids for an autoimmune or chronic inflammatory disease
    • with nephrotic syndrome
  • Patients with an osteomeningeal defect or who are candidates for implants
  • Non-immunocompromised patients with an underlying condition predisposing them to invasive pneumococcal infections:
    • cyanotic congenital heart disease, heart failure
    • chronic respiratory failure, chronic obstructive pulmonary disease, emphysema
    • severe asthma requiring ongoing treatment
    • renal failure
    • chronic liver disease of any origin
    • diabetes not controlled by diet alone.

Vaccination schedules based on age and risk are detailed in the vaccination calendar.

For more information on vaccination, visit vaccination-info-service